GlobalData analysts are predicting an Alzheimer’s disease market boom, tipping its value across major regions to increase ...
PsyPost on MSN3d
Focused ultrasound shows promise in treating Alzheimer’s by reducing amyloid plaquesA new study published in the Journal of Neurosurgery highlights the potential of focused ultrasound technology in treating ...
The Amazing Times on MSN3d
Five Common Medications That May Increase Your Risk of DementiaDementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...
Expanded clinical practice guidelines aim to empower all clinicians, regardless of specialty or practice setting to evaluate ...
New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according to a report. The report by GlobalData, a data and analytics company, showed ...
The Phase Ia trial is designed to assess the safety and efficacy of the company’s drug designed to target chemicals thought ...
Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease ...
8d
Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...
"During the early stage, it's possible for people with dementia to live well by taking control of their health and wellness, ...
ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on developing precision therapies for neurodegenerative diseases, today announced the initiation of its Phase 1b ...
Share on PinterestThe virus causing cold sores may also be linked to Alzheimer’s risk, a new study suggests. Image credit: ...
The Alzheimer’s disease market is expected to grow at a CAGR of 23.4% from $2.4bn in 2023 to $19.3bn by 2033 across the 8MM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback